| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.1999.TB08500.X |
| P698 | PubMed publication ID | 10415564 |
| P2093 | author name string | Chang PL | |
| P2860 | cites work | Biocompatibility of mannuronic acid-rich alginates | Q45881904 |
| Constant delivery of proinsulin by encapsulation of transfected cells | Q45882746 | ||
| A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension | Q45884448 | ||
| Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency | Q24626591 | ||
| Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients | Q28279918 | ||
| Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts--an alternate approach to somatic gene therapy | Q28300694 | ||
| Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth | Q28594980 | ||
| Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis | Q34205101 | ||
| Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules | Q34416345 | ||
| Alginate as immobilization matrix for cells | Q35285100 | ||
| The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor | Q35884401 | ||
| Gaucher disease as a paradigm of current issues regarding single gene mutations of humans | Q36353819 | ||
| Delivery of recombinant gene product to canines with nonautologous microencapsulated cells | Q41064182 | ||
| Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. | Q41074833 | ||
| Secretion of recombinant proteins from hydroxyethyl methacrylate-methyl methacrylate capsules | Q41176154 | ||
| Growth retardation--an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts | Q41248365 | ||
| Delivery of recombinant gene products with microencapsulated cells in vivo | Q41535092 | ||
| Expression of human factor IX by microencapsulated recombinant fibroblasts. | Q41550772 | ||
| Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis | Q43798918 | ||
| Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts | Q44203713 | ||
| T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. | Q45866838 | ||
| Growth of recombinant fibroblasts in alginate microcapsules | Q45878839 | ||
| The TMC Worldwide Gene Therapy Enrollment Report, end 1996. | Q45881392 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 146-158 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Encapsulation for somatic gene therapy | |
| P478 | volume | 875 |
| Q24806569 | Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria |
| Q37879987 | Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases |
| Q34003138 | Cellular transplants as sources for therapeutic agents |
| Q43061530 | Design and fabrication of anatomical bioreactor systems containing alginate scaffolds for cartilage tissue engineering. |
| Q53617874 | Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. |
| Q43905980 | MTS colorimetric assay in combination with a live-dead assay for testing encapsulated L929 fibroblasts in alginate poly-L-lysine microcapsules in vitro |
Search more.